Plasma Shh levels reduced in pancreatic cancer patients.
Plasma Shh levels reduced in pancreatic cancer patients.
复制标题
DOI:
10.1097/mpa.0b013e31824a0eeb
复制
发表时间:
2012-10
期刊:
影响因子:
2.9
通讯作者:
Merchant JL
中科院分区:
文献类型:
--
作者:
El-Zaatari M;Daignault S;Tessier A;Kelsey G;Travnikar LA;Cantu EF;Lee J;Plonka CM;Simeone DM;Anderson MA;Merchant JL
Normally, sonic hedgehog (Shh) is expressed in the pancreas during fetal development and transiently after tissue injury. Although pancreatic cancers express Shh, it is not known if the protein is secreted into the blood and whether its plasma levels change with pancreatic transformation. The goal of this study was to develop an ELISA to detect human Shh in blood, and determine the levels in subjects with and without pancreatic cancer. A human Shh ELISA assay was developed, and plasma Shh levels were measured in blood samples from normal volunteers and subjects with pancreatitis or pancreatic cancer. The biological activity of plasma Shh was tested using NIH-3T3 cells. The average levels of Shh in human blood were lower in pancreatitis and pancreatic cancer patients than in normal individuals. Hematopoietic cells did not express Shh suggesting that Shh is secreted into the bloodstream. Plasma fractions enriched for Shh did not induce Gli-1 mRNA suggesting that the protein was not biologically active. Shh is secreted from tissues and organs into the circulation but its activity is blocked by plasma proteins. Reduced plasma levels were found in pancreatic cancer patients, but alone were not sufficient to predict pancreatic cancer.